CrushSCI.com
378.8Average days
284.5Median days
218Fastest days
728Longest days
1242025 publications

Paper Review Records

All Paper Review Records

4 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

728 days

Adherence of Patients With Breast Carcinoma and Gynecologic Genital Carcinoma in the Use of Integrative Therapy Recommendations

Authors
Milena Beierlein; Carolin C. Hack; Anna-Katharin Theuser; Katharina Au; Lena Brueckner; Matthias W. Beckmann; Katharina SeitzShow moreShow less
Affiliations
1. Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen–European Metropolitan Area Nuremberg (CCC ER-EMN), 9171Friedrich Alexander University of Erlangen–Nuremberg, Erlangen, Germany; 2. 27168Institute for Women’s Health/Institut Fuer Frauengesundheit GmbH, Erlangen, GermanyShow moreShow less
Official full-text evidence DOI Publisher page
298 days

The Mechanism Underlying Inhibition of Colorectal Cancer Invasion by Quxie Capsule Through CRK-RAC Signaling Pathway Regulation

Authors
Jiang-yu Bian; Yu-xing Sun; Lin-feng Wang; Yu-fei Yang; Tong ZhangShow moreShow less
Affiliations
1. Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, ChinaShow moreShow less
Official full-text evidence DOI Publisher page
271 days

Efficacy and Safety of Viscum album L. in Patients With Triple-Negative Breast Cancer Receiving Immune Checkpoint Inhibitors: A Protocol for an Open-Label Randomized Clinical Trial

Authors
Jee Young Lee; Eun Ju Ko; Sang Hyung Lee; Sung Eun Hong; Myung Han HyunShow moreShow less
Affiliations
1. Integrative Cancer Center, 578132CHA Ilsan Medical Center, CHA University, Goyang-si, Gyeonggi-do, Republic of KoreaShow moreShow less
Official full-text evidence DOI Publisher page
218 days

Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Authors
Yichao Wang; Lijing Jiao; Zhiwei Chen; Jianfang Xu; Jiaming Che; Hai Huang; Lei Zhang; Xiaoyong Shen; Yi Yang; Tiancheng Zhao; Jie Zhang; Di Zhou; Qin Wang; Jialin Yao; Wenxiao Yang; Chenbing Sun; Jiaqi Li; Ling Bi; Rongzhen Ding; Ian Goodfellow; Yabin Gong; Ling XuShow moreShow less
Affiliations
1. Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, P.R. China; 2. Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, P.R. China; 3. Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, P.R. China; 4. Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University, P.R. China; 5. Department of Pneumology, Changzheng Hospital, The Naval Medical University, Shanghai, P.R. China; 6. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, P.R. China; 7. Department of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, P.R. China; 8. Department of Thoracic Surgery, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, P.R. China; 9. Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, P.R. China; 10. Department of Oncology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, P.R. China; 11. Department of Pathology, University of Cambridge, UKShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.